Breast Cancer

	07/08/2009	Patient Scenarios for Everyday Practice: Managing Advanced HER2-Positive Breast Cancer Throughout the Disease Continuum
	07/08/2009	Tailoring Treatment for Metastatic Breast Cancer Based on Tumor Biology: An Illustrative Case, Part 1
	07/08/2009	Tailoring Treatment for Metastatic Breast Cancer Based on Tumor Biology: An Illustrative Case, Part 2
	06/23/2009	Taking Stock of the Current Research in Early-Stage Breast Cancer: Can the New Data Help Refine the Use of Endocrine and Cytotoxic Therapies?
	05/22/2009	Cutaneous Metastasis of Breast Carcinoma Presenting as Alopecia Neoplastica
	05/19/2009	Optimizing the Use of Chemotherapy as the Backbone of Breast Cancer Treatment: An Update of the Latest Evidence
	05/14/2009	Applying Key Biomarkers in Oncology: From Biospecimen Preparation and Storage to Clinical Implications
	04/06/2009	Finding Ways to Prevent, Circumvent, or Overcome Cardiovascular Toxicity Associated With Modern Breast Cancer Therapies
	04/06/2009	Putting the Cardiovascular Safety of Breast Cancer Therapies Into Perspective: Pleading the Case for a Balanced View
	04/06/2009	Appropriate Risk Assessment, Management, and Follow-Up Ensure Optimal Cardiovascular Outcomes in Patients With Breast Cancer
	04/02/2009	New Insights Into Efficacy, Safety, and Optimal Use of Endocrine Therapies in Breast Cancer
	04/02/2009	Switching and Up-Front Approaches to Hormone Therapy in Early Breast Cancer: Have the Latest Data Confirmed the Best Time to Introduce an Aromatase Inhibitor?
	04/02/2009	Do All Drugs With Beneficial Effect on Bone Health Also Prevent Breast Cancer Recurrence?
	04/02/2009	Prognostic or Predictive Tools and Strategies for Overcoming Endocrine Resistance: Still Investigational or Ready for Prime Time?
	10/03/2008	Progress in Detecting and Managing HER2-Positive Breast Cancer: A Brief Clinical Update
	09/19/2008	Evolving Role of Targeted Therapy in Early-Stage Breast Cancer: Highlights of Recent Clinical Data
	08/28/2008	Overcoming Challenges in Advanced Breast Cancer: How to Optimally Use Available Therapies
	08/08/2008	Moving Towards More Tailored Use of Antiangiogenic Therapies in Breast Cancer: A Clinical Update
	05/27/2008	Optimizing Use of Biologics in Breast Cancer Therapy: Controversies, New Data, and Clinical Implications
	04/29/2008	Breast Problems:  Common Problems in Adults (non-pregnant)
	04/21/2008	Chemotherapy Resistance in Breast Cancer: Which Mechanisms Have Clinical Relevance?
	04/21/2008	New Opportunities to Overcome Chemotherapy Resistance in Breast Cancer: Focus on the Epothilones
	04/01/2008	Targeted Therapy in Breast Cancer: Updates on Established and Novel Agents in Early Stage and Metastatic Disease
	04/01/2008	Disputing the One-Size-Fits-All Approach: New Data Highlight the Importance of Individualized Breast Cancer Therapy
	04/01/2008	Antiangiogenic Therapy in Breast Cancer: Is it Here to Stay?
	04/01/2008	Re-Examining Optimal Use of HER2-Targeted Therapies in Breast Cancer
	04/01/2008	Evolving Role of Endocrine Therapy in Breast Cancer: What Does the Latest Evidence Show?
	03/17/2008	Optimizing Use of Cytotoxic Agents in Breast Cancer Therapy: Controversies, New Data, and Clinical Implications
	02/21/2008	HER2 Testing in Breast Cancer: Where Do We Presently Stand?
	02/21/2008	HER2 Testing in Breast Cancer: Will Multigene Arrays Be the Standard in Future?